The global vaccine market size reached USD 45.20 Billion in 2021 and is expected to register a revenue CAGR of 9.7% during the forecast period, according to latest analysis by Emergen Research. Increase in infectious diseases in developing countries is one of the key factors driving market revenue growth. Global rise in prevalence of infectious illnesses increases healthcare burden on countries and has an impact on their socio-economic growth. In addition, rise in prevalence of infectious diseases, such as malaria, influenza, hepatitis, and HIV/AIDS, is driving revenue growth. Moreover, emergence of drug-resistant microbial strains has hampered efforts to combat infectious illnesses such as pneumonia, cholera, malaria, and diarrhea, among others.
The constant efforts of prominent players to develop newer and modern technologies and product advancements are expected to drive the growth of the industry over the coming years. The report studies the extensive business expansion plans and advancements in R&D activities and product portfolio. The report offers a clear understanding of the alliances in the market, such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches and brand promotions, and corporate deals.
The leading market contenders listed in the report are:
Pfizer, Inc., CSL Limited, Merck & Co., Inc., AstraZeneca, Johnson & Johnson, Serum Institute of India Pvt., Ltd., GlaxoSmithKline PLC, Sanofi Pasteur SA, Emergent Biosolutions, Inc., and Biological E
The research study examines historic data from 2018 and 2020 to draw forecasts until 2030. The timeline makes the report an invaluable resource for readers, investors, and stakeholders looking for key insights in readily accessible documents with the information presented in the form of tables, charts, and graphs.
The report bifurcates the Vaccine market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.
Segments Covered in this report are:
Type Outlook (Revenue, USD Billion; 2018-2028)
Monovalent Vaccines
Multivalent Vaccines
Patient Type Outlook (Revenue, USD Billion; 2018-2028)
Pediatric Patients
Adult Patients
Technology Outlook (Revenue, USD Billion; 2018-2028)
Inactivated & Subunit Vaccines
Conjugate Vaccines
Recombinant Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
The research report offers a comprehensive regional analysis of the market with regards to production and consumption patterns, import/export, market size and share in terms of volume and value, supply and demand dynamics, and presence of prominent players in each market.
North America (U.S., Canada) Europe (U.K., Italy, Germany, France, Rest of EU) Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC) Latin America (Chile, Brazil, Argentina, Rest of Latin America) Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key reasons to buy the Global Vaccine Market report:
The latest report comprehensively studies the global Vaccine market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.
The report offers an insightful analysis of the regional outlook of the market.
It offers a detailed account of the end-use applications of the products & services offered by this industry.
The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.